These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26516132)

  • 41. Epidermodysplasia Verruciformis After Hematopoietic Stem Cell Transplantation in a Patient With Severe Combined Immunodeficiency Syndrome.
    Bostan E; Akdogan N; Gokoz O
    Am J Dermatopathol; 2021 May; 43(5):e65-e67. PubMed ID: 33577180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acquired epidermodysplasia verruciformis occurring in a renal transplant recipient.
    Henley JK; Hossler EW
    Cutis; 2017 May; 99(5):E9-E12. PubMed ID: 28632809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus.
    Ferronika P; Sijmons RH; Febiyanto N; Radiono S; Widodo I
    Am J Dermatopathol; 2020 Nov; 42(11):e156-e158. PubMed ID: 32675468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of epidermodysplasia verruciformis (EV) with human papillomavirus 16 (HPV16) DNA detected in the skin lesions: can HPV16 infect patients with EV?
    Hayashi S; Hatamochi A; Soutome A; Hamasaki Y; Yamazaki S; Kawase M; Tadano M; Kitasato H
    Int J Dermatol; 2011 Sep; 50(9):1168-70. PubMed ID: 22126886
    [No Abstract]   [Full Text] [Related]  

  • 45. Remission of an epidermodysplasia verruciformis-like eruption in an HIV-positive man long after immune restoration.
    Lecapitaine AL; Perronne V; Granier F
    Eur J Dermatol; 2015; 25(5):488-90. PubMed ID: 26243233
    [No Abstract]   [Full Text] [Related]  

  • 46. Epidermodysplasia verruciformis in the setting of graft-versus-host disease.
    Kunishige JH; Hymes SR; Madkan V; Wyatt AJ; Uptmore D; Lazar AJ; Giralt S; Rady P; Tyring S
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S78-80. PubMed ID: 17938030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.
    Janssen K; Lucker GP; Houwing RH; van Rijssel R
    Int J Dermatol; 2007 Nov; 46 Suppl 3():45-7. PubMed ID: 17973891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus and squamous cell cancer of the skin--epidermodysplasia verruciformis-associated human papillomavirus revisited.
    Arnold AW; Hofbauer GF
    Curr Probl Dermatol; 2012; 43():49-56. PubMed ID: 22377919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    Moore S; Rady P; Tyring S
    Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquired epidermodysplasia verruciformis or generalized verrucosis? A clinical and virological comparative study.
    Cheng CY; Lin CY; Lai CH; Chen CB; Chung WH
    J Dermatol; 2021 Sep; 48(9):1414-1418. PubMed ID: 34212429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma.
    Ko CJ; Iftner T; Barr RJ; Binder SW
    J Cutan Pathol; 2007 Jan; 34(1):44-8. PubMed ID: 17214854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermodysplasia verruciformis with neurological manifestations.
    Al Rubaie S; Breuer J; Inshasi J; Al Saady S; Fathi I
    Int J Dermatol; 1998 Oct; 37(10):766-71. PubMed ID: 9802687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidermodysplasia verruciformis and malignant thymoma.
    Jacyk WK; Hazelhurst JA; Dreyer L; Coccia-Portugal MA
    Clin Exp Dermatol; 1993 Jan; 18(1):89-91. PubMed ID: 8440067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    Baskan EB; Tunali S; Adim SB; Turan A; Toker S
    J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus.
    Holmes C; Chong AH; Tabrizi SN; Downes N; Nindl I
    Australas J Dermatol; 2009 Feb; 50(1):44-7. PubMed ID: 19178492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Types of human papillomavirus isolated from Japanese patients with epidermodysplasia verruciformis.
    Kanda R; Tanigaki T; Kitano Y; Yoshikawa K; Yutsudo M; Hakura A
    Br J Dermatol; 1989 Oct; 121(4):463-9. PubMed ID: 2560401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HPV-20-induced epidermodysplasia verruciformis].
    Wätzig V; Jablonská S
    Hautarzt; 1987 Sep; 38(9):521-4. PubMed ID: 2826363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
    Przybyszewska J; Zlotogorski A; Ramot Y
    J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy.
    Carré D; Dompmartin A; Verdon R; Comoz F; Le Brun E; Freymuth F; Leroy D
    Int J Dermatol; 2003 Apr; 42(4):296-300. PubMed ID: 12694498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.